ArticleFrontiers in medicine2026
Unexpected perinatal death caused by an occult MTM1 mutation: a case report.
Article in Frontiers in medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Genetic mutations can lead to miscarriages, perinatal deaths, and abnormalities in fetal development. Sometimes, the regular prenatal test cannot identify some rare diseases, but whole-exome sequencing can be performed. Whole-exome sequencing testing is not a routine prenatal test unless there is a family history or a history of adverse pregnancy due to a genetic disorder. Case presentation: We reported a case of stillbirth caused by a rare genetic disease, secondary to an MTM1 gene mutation. It was found to have no abnormality during childbirth; even electronic fetal monitoring showed no signs of fetal distress. However, delivery concluded with a stillborn birth, and the offspring having no crying, poor muscle tone, and pale skin. Due to the unclear cause of stillbirth, the patient requested further diagnostic genetic testing to identify a cause. The MTM1 gene hemizygous variant was detected by whole-exome sequencing. Conclusion: Stillbirth due to genetic mutations may not be detected by non-invasive prenatal testing or chromosome copy number variant analysis. Broad Next-Generation Sequencing, such as whole-exome sequencing, has the potential to identify genetic causes that are missed by non-invasive prenatal testing or chromosomal microarray. The indications for the whole-exome sequencing test for pregnant women may need further discussion.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.